For example, Luminal and HER2(+) breast cancers exhibited higher numbers of CD34(+)/CD10(+)/c-Kit(+)/vimentin(+) telocytes than triple-negative breast cancers. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.